Said Suliman, A.; Khoder, M.; Tolaymat, I.; Webster, M.; Alany, R.G.; Wang, W.; Elhissi, A.; Najlah, M.
Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines. Pharmaceutics 2021, 13, 84.
https://doi.org/10.3390/pharmaceutics13010084
AMA Style
Said Suliman A, Khoder M, Tolaymat I, Webster M, Alany RG, Wang W, Elhissi A, Najlah M.
Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines. Pharmaceutics. 2021; 13(1):84.
https://doi.org/10.3390/pharmaceutics13010084
Chicago/Turabian Style
Said Suliman, Ammar, Mouhamad Khoder, Ibrahim Tolaymat, Matt Webster, Raid G. Alany, Weiguang Wang, Abdelbary Elhissi, and Mohammad Najlah.
2021. "Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines" Pharmaceutics 13, no. 1: 84.
https://doi.org/10.3390/pharmaceutics13010084
APA Style
Said Suliman, A., Khoder, M., Tolaymat, I., Webster, M., Alany, R. G., Wang, W., Elhissi, A., & Najlah, M.
(2021). Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines. Pharmaceutics, 13(1), 84.
https://doi.org/10.3390/pharmaceutics13010084